DIMENSIONAL FUND ADVISORS LP - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$61,688
-73.9%
35,865
-77.1%
0.00%
Q1 2023$236,134
+85455.8%
156,456
-9.3%
0.00%
Q4 2022$276
-99.9%
172,572
-4.4%
0.00%
Q3 2022$262,000
-64.0%
180,580
-54.5%
0.00%
Q2 2022$727,000
-66.4%
397,241
-50.9%
0.00%
-100.0%
Q1 2022$2,161,000
-4.4%
809,140
+55.0%
0.00%0.0%
Q4 2021$2,260,000
+37.5%
522,027
+61.6%
0.00%0.0%
Q3 2021$1,644,000
-59.1%
323,029
-49.1%
0.00%0.0%
Q2 2021$4,016,000
+0.9%
634,393
+23.2%
0.00%0.0%
Q1 2021$3,981,000
+9.7%
515,051
-7.0%
0.00%0.0%
Q4 2020$3,629,000
-4.4%
553,904
-2.9%
0.00%
-50.0%
Q3 2020$3,795,000
-20.2%
570,6040.0%0.00%0.0%
Q2 2020$4,753,000
+4.4%
570,604
-3.9%
0.00%0.0%
Q1 2020$4,552,000
-3.8%
593,667
+4.2%
0.00%0.0%
Q4 2019$4,733,000
+57.7%
569,564
+40.1%
0.00%
+100.0%
Q3 2019$3,002,000
-23.4%
406,645
+16.5%
0.00%
-50.0%
Q2 2019$3,917,000
+159.2%
349,194
+148.4%
0.00%
+100.0%
Q1 2019$1,511,000
+121.9%
140,575
+211.6%
0.00%
Q4 2018$681,00045,1150.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders